首页> 外文期刊>Medical Physics >Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy
【24h】

Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy

机译:基于非刚性配准的基于超声引导的基于CT的HDR前列腺近距离放射治疗的前列腺CT分割方法

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The technological advances in real-time ultrasound image guidance for high-dose-rate (HDR) prostate brachytherapy have placed this treatment modality at the forefront of innovation in cancer radiotherapy. Prostate HDR treatment often involves placing the HDR catheters (needles) into the prostate gland under the transrectal ultrasound (TRUS) guidance, then generating a radiation treatment plan based on CT prostate images, and subsequently delivering high dose of radiation through these catheters. The main challenge for this HDR procedure is to accurately segment the prostate volume in the CT images for the radiation treatment planning. In this study, the authors propose a novel approach that integrates the prostate volume from 3D TRUS images into the treatment planning CT images to provide an accurate prostate delineation for prostate HDR treatment.Methods: The authors' approach requires acquisition of 3D TRUS prostate images in the operating room right after the HDR catheters are inserted, which takes 1-3 min. These TRUS images are used to create prostate contours. The HDR catheters are reconstructed from the intraoperative TRUS and postoperative CT images, and subsequently used as landmarks for the TRUS-CT image fusion. After TRUS-CT fusion, the TRUS-based prostate volume is deformed to the CT images for treatment planning. This method was first validated with a prostate-phantom study. In addition, a pilot study of ten patients undergoing HDR prostate brachytherapy was conducted to test its clinical feasibility. The accuracy of their approach was assessed through the locations of three implanted fiducial (gold) markers, as well as T2-weighted MR prostate images of patients.Results: For the phantom study, the target registration error (TRE) of gold-markers was 0.41 ±0.11 mm. For the ten patients, the TRE of gold markers was 1.18±0.26 mm; the prostate volume difference between the authors' approach and the MRI-based volume was 7.28%±0.86%, and the prostate volume Dice overlap coefficient was 91.89%±1.19%.Conclusions: The authors have developed a novel approach to improve prostate contour utilizing intraoperative TRUS-based prostate volume in the CT-based prostate HDR treatment planning, demonstrated its clinical feasibility, and validated its accuracy with MRIs. The proposed segmentation method would improve prostate delineations, enable accurate dose planning and treatment delivery, and potentially enhance the treatment outcome of prostate HDR brachytherapy.
机译:目的:用于高剂量率(HDR)前列腺近距离放射治疗的实时超声图像引导技术的进步,使这种治疗方式处于癌症放射治疗创新的最前沿。前列腺HDR治疗通常涉及将HDR导管(针)置于经直肠超声(TRUS)引导下的前列腺中,然后基于CT前列腺图像生成放射治疗计划,然后通过这些导管传递高剂量的放射。这种HDR程序的主要挑战是在放射治疗计划中准确分割CT图像中的前列腺体积。在这项研究中,作者提出了一种新颖的方法,该方法将3D TRUS图像的前列腺体积整合到治疗计划CT图像中,从而为前列腺HDR治疗提供准确的前列腺轮廓。方法:作者的方法需要在3D TRUS图像中获取3D TRUS前列腺图像。插入HDR导管后立即在手术室中进行,这需要1-3分钟。这些TRUS图像用于创建前列腺轮廓。从术中TRUS和术后CT图像重建HDR导管,然后将其用作TRUS-CT图像融合的界标。在TRUS-CT融合后,基于TRUS的前列腺体积会变形为CT图像以进行治疗计划。该方法首先通过前列腺模型研究进行了验证。此外,对十名接受HDR前列腺近距离放射治疗的患者进行了初步研究,以测试其临床可行性。通过三个植入的基准(金)标记的位置以及患者的T2加权MR前列腺图像评估了他们方法的准确性。结果:对于幻像研究,金标记的目标配准误差(TRE)为0.41±0.11毫米对于十例患者,金标记物的TRE为1.18±0.26 mm;作者的方法与基于MRI的方法之间的前列腺体积差异为7.28%±0.86%,前列腺体积Dice重叠系数为91.89%±1.19%。结论:作者开发了一种新颖的方法来利用前列腺轮廓在基于CT的前列腺HDR治疗计划中基于术中TRUS的前列腺体积,证明了其临床可行性,并通过MRI验证了其准确性。拟议的分割方法将改善前列腺的轮廓,实现准确的剂量规划和治疗交付,并有可能增强前列腺HDR近距离放射治疗的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号